Skip to content

Intravenous Tranexamic Acid During Rhytidectomy

Effects of Intravenous Tranexamic Acid During Rhytidectomy - a Randomized, Controlled, Double-blind Pilot Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03970213
Enrollment
40
Registered
2019-05-31
Start date
2019-05-30
Completion date
2019-08-30
Last updated
2019-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding, Bruising Face, Swelling Lips & Face

Keywords

Tranexamic acid, Rhytidectomy, Facelift

Brief summary

This is a prospective, randomized, double-blind study investigating whether intravenous tranexamic acid has any effect on rhytidectomy surgery, or the subsequent postoperative sequelae. Intraoperative bleeding and postoperative ecchymosis and edema are subjectively rated and complications are noted.

Detailed description

This is a prospective, randomized, double-blind pilot study investigating whether intravenous tranexamic acid has any effect on rhytidectomy surgery, or the subsequent postoperative sequelae. Intraoperative bleeding is rated on a scale of mild, moderate, or severe and given a score of 1-3. Postoperative ecchymosis and edema are subjectively rated by both patient and surgeon on postoperative days 1, 6, and 9 using a similar mild/moderate/severe scale and scored 1-3, respectively. Any surgical or postoperative complications are noted. Scores are aggregated for statistical analysis.

Interventions

IV TXA given during surgery

IV saline given during surgery

Sponsors

Glasgold Group Plastic Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Only the CRNA who is administering the medications is unmasked until completion of the data collection period.

Intervention model description

Randomized, double-blind

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Undergoing rhytidectomy surgery at Glasgold Group Plastic Surgery

Exclusion criteria

* History of bleeding disorder, history of thromboembolic events, history of seizure, active use of oral contraceptive pills or hormone replacement therapy, participant preference

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative bleedingSurgical timeSubjective measure of intraoperative blood loss (mild, moderate, or severe)
Postoperative ecchymosisPostoperative day 1Subjective measure of bruising rated as mild, moderate, or severe
Postoperative edemaPostoperative day 1Subjective measure of swelling rated as mild, moderate, or severe

Secondary

MeasureTime frameDescription
Postoperative hematoma/seroma10 days postoperativeDocumentation of any postoperative collections seen during the first 10 days following surgery
Complications10 days postoperativeDocumentation of any surgical or postoperative complications

Countries

United States

Contacts

Primary ContactMark J Glasgold, MD
mglasgold@gmail.com732-846-6540
Backup ContactJustin C Cohen, MD
justinccohen@gmail.com732-846-6540

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026